LLY
1,067.68
+0.83%↑
JNJ
205.97
+1.01%↑
ABBV
229.49
-2.82%↓
UNH
318.47
-0.28%↓
AZN
91.56
+0.6%↑
LLY
1,067.68
+0.83%↑
JNJ
205.97
+1.01%↑
ABBV
229.49
-2.82%↓
UNH
318.47
-0.28%↓
AZN
91.56
+0.6%↑
LLY
1,067.68
+0.83%↑
JNJ
205.97
+1.01%↑
ABBV
229.49
-2.82%↓
UNH
318.47
-0.28%↓
AZN
91.56
+0.6%↑
LLY
1,067.68
+0.83%↑
JNJ
205.97
+1.01%↑
ABBV
229.49
-2.82%↓
UNH
318.47
-0.28%↓
AZN
91.56
+0.6%↑
LLY
1,067.68
+0.83%↑
JNJ
205.97
+1.01%↑
ABBV
229.49
-2.82%↓
UNH
318.47
-0.28%↓
AZN
91.56
+0.6%↑
24u
Huidig
Min
2.5
Max
2.62
Aanbevelingen | Buy |
|---|---|
12 Maanden Prognose | +315.06% upside |
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
1 okt 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Lezen
10 mrt 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Lezen
10 mrt 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Lezen
10 mrt 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Lezen
10 mrt 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Lezen
10 mrt 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Lezen
10 mrt 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lezen
10 mrt 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lezen
Prijswijziging
By TipRanks
12 Maanden Prognose
Gemiddelde 10.75 USD 315.06%
Hoogste 17 USD
Laagste 4.5 USD
Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Fortress Biotech Inc - Dist. in de afgelopen 3 maanden.
By TipRanks
Buy
2 ratings
2
Buy
0
Hold
0
Sell
Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Fortress Biotech Inc - Dist in de afgelopen 3 maanden.
$